CuraYou's ProWave Deep Healing Pad™ delivers red and infrared light therapy for osteoporosis in a device you can use at home every day. It takes the kind of light treatment that has been studied for decades in clinical and laboratory settings, usually with professional lasers, and builds it into a flexible pad that wraps around the hip, spine, or forearm and treats the area in one session. The clinical research behind light therapy for osteoporosis is early but consistently positive: three human studies have found significant gains in bone mineral density, and the preclinical evidence across more than a dozen independent studies is remarkably uniform. But research only helps the person sitting at home with a bone density diagnosis if it is built into something they can actually use. This article covers exactly how the device does that: which wavelengths it uses, why it uses LEDs instead of lasers, how much power it delivers, and what treatment routine CuraYou recommends.
Part of our complete guide to Red and Infrared Light Therapy for Osteoporosis.
Key Takeaways
- The wavelengths match the research. The Cura ProWave Deep Healing Pad™ delivers 850 nm near-infrared light from 240 light chips and 660 nm red light from 120 light chips, 360 in total, at 200 mW/cm² across an 18 × 8 inch flexible pad. Both wavelengths sit within the range studied in the osteoporosis literature: 660 nm for stimulating bone-building cells and inhibiting bone-dissolving cells, and near-infrared for reaching deeper bone tissue. Shokri et al. (2023) tested 660, 810, and 940 nm in estrogen-depleted animals and found all three improved bone density with no meaningful difference among them.
- The LED evidence for bone is direct. Light therapy works by wavelength and dose, not by the type of device. Lim et al. (2014) demonstrated that 635 nm LED light significantly inhibited bone-dissolving osteoclast formation. Cardoso et al. (2021) showed that LED stimulated osteoblast proliferation and viability. Dalapria et al. (2022) found that 850 nm LED treatment improved bone remodeling and maturation after tooth extraction.
- The protocol matches what worked in trials. CuraYou recommends daily 20-minute sessions using the pre-set modes, in line with the clinical finding that consistent, accumulated dosing produced bone density gains measurable within 8 weeks and holding at follow-up. Three modes (red only, infrared only, or combined) let you target surface tissue, deeper bone tissue, or both.
What the Research Requires
How Red and Infrared Light Therapy Help Osteoporosis
Red and infrared light therapy (photobiomodulation) works on several drivers of bone loss at once. It restores the cellular energy that bone-building cells need to produce collagen and deposit minerals. It stimulates those bone-building osteoblasts to multiply, mature, and get to work: Tani et al. (2018) found that red light at 635 nm increased markers of active bone formation in human osteoblasts and their precursors, and the treated cells went on to deposit mineralized bone nodules. On the other side of the equation, it slows the bone-dissolving osteoclasts that drive the imbalance at the heart of osteoporosis: Lim et al. (2014) showed that 635 nm LED light disrupted the structural scaffolding these cells need to attach to bone and break it down. It also reduces the chronic inflammation that accelerates bone loss, defends bone cells from oxidative stress, improves blood flow to bone tissue, and supports the estrogen-related pathways disrupted at menopause. The clinical evidence now includes a randomized clinical trial by Mohammadi et al. (2022) that found significant increases in bone mineral density and in two blood markers of active bone building in people with osteoporosis, a second human study by Mohammadzadeh et al. (2024) that found bone density gains at the hip and forearm lasting at follow-up, and a controlled trial by Abdelaal et al. (2017) that found significant bone density gains in elderly osteoporosis patients while an untreated group showed no change. The deeper mechanisms are covered in our complete guide to red light therapy for osteoporosis and our how-it-works explainer.
Wavelength, Dose, and Protocol
For any device to deliver these benefits, the research points to specific requirements. Red light in the 630-660 nm range is absorbed by cytochrome c oxidase, the enzyme in the cell's mitochondria that drives the entire photobiomodulation response (Hamblin, 2017). Near-infrared light around 800-940 nm penetrates deeper, reaching bone tissue beneath skin and muscle. Shokri et al. (2023) conducted the most complete wavelength comparison to date for osteoporosis, testing 660, 810, and 940 nm in estrogen-depleted rats, and found that all three significantly improved bone density compared to untreated controls, with no meaningful difference among wavelengths. The bone-building effect held across the full red-to-near-infrared range. That same study found the light therapy groups matched the results of a standard osteoporosis drug (zoledronic acid), and combining the two produced the best outcomes of all.
Dose matters as much as wavelength. Huang et al. (2009) documented a biphasic dose response across many cell types: low to moderate doses stimulate cells, while excessive doses can reduce or reverse the benefit. This means more light is not always better, and the right dose matters. Bossini et al. (2012) tested two different dosages of 830 nm laser in osteoporotic rats and found both produced significantly more newly formed bone and better-organized collagen compared to untreated controls, with similar outcomes at the two doses, confirming that staying within the effective dosing window is what matters.
The human clinical trials used treatment courses of multiple sessions per week over several weeks. Mohammadzadeh et al. (2024) applied 830 nm light three times weekly for eight weeks and found bone density gains at the hip and forearm that held at the 15-week follow-up. Bone renews slowly, so DEXA scans typically detect meaningful change over 6 to 12 months, though blood markers of active bone formation can rise within weeks. The therapy has a strong safety record. No significant adverse effects were reported in any of the osteoporosis studies, and a 2025 umbrella review by Son et al. supports photobiomodulation as a non-invasive, well-tolerated therapy across many conditions. What matters for results is delivering the right wavelengths at enough power with consistent daily use, parameters that vary widely across consumer devices.
The Mohammadi trial was the first to measure bone density directly in osteoporosis patients receiving photobiomodulation, and the result was a significant increase. When I look at the preclinical data underneath that, the consistency across independent groups and wavelengths is what stands out. Shokri's wavelength comparison found that 660, 810, and 940 nm all improved bone density, and both dosages in the Bossini study worked. That tells me the therapeutic window is broader than people assume. What narrows the window is power. You need enough energy reaching the bone, and you need it consistently. Those are the parameters I would focus on in a home device.— Dr. William Carter, MD
Why the Cura ProWave Deep Healing Pad Uses LEDs Instead of Lasers
Most of the clinical evidence for light therapy in osteoporosis comes from professional lasers used in research settings. So if the strongest human evidence used lasers, why does the Cura ProWave Deep Healing Pad use LEDs?
The Biology Does Not Require a Laser
The cellular response to light depends on the wavelength and dose, not on the type of device. A photon at a given wavelength triggers the same response in the cell whether it comes from a laser or an LED. Hamblin (2017) established that the biological effects depend on wavelength, dose, and intensity, not on the laser-versus-LED distinction. The most thorough review of the question, by Heiskanen and Hamblin (2018) of Massachusetts General Hospital and Harvard, concluded that light therapy does not depend on lasers or coherence, and that LED therapy appears as effective as laser therapy for surface-tissue applications at matched wavelength and dose.
The LED evidence for bone specifically is direct and growing. Lim et al. (2014) demonstrated that 635 nm LED light significantly inhibited osteoclast formation by disrupting the actin cytoskeleton these cells need to function, a result that directly addresses the bone-breakdown side of osteoporosis. Cardoso et al. (2021) found that both red laser and LED stimulated osteoblast proliferation, viability, and mineralization in rat bone cells, with the LED producing effects comparable to the laser. Dalapria et al. (2022) showed that 850 nm LED treatment improved bone remodeling and maturation in an animal model. And De Oliveira et al. (2022) reviewed both low-level laser and LED and concluded light therapy offers a non-invasive, drug-free method for pain control with no reported side effects across common musculoskeletal conditions.
LED Covers the Treatment Area at Once
Osteoporosis affects the hip, spine, wrist, and forearm most commonly. A clinical laser treats one small point at a time and needs a trained practitioner to move the probe across the treatment area point by point. An LED array built into a flexible pad covers the entire area in one session, so every part of the target site is treated simultaneously. The Cura ProWave Deep Healing Pad's 360-LED array and 18 x 8 inch flexible pad deliver area-wide coverage that a single-point laser probe cannot match without manual repositioning and clinical supervision.
LED Makes Daily Home Use Possible
The clinical trials that found bone density improvements used treatment courses of several sessions per week over weeks and months. Clinical laser sessions mean a clinic visit each time, administered by trained staff, which is impractical to sustain over the months and years that bone health requires. Bone renewal is slow. A home LED device lets you treat every day, which is the frequency the evidence rewards, without specialized training or supervision. For a condition like osteoporosis where long-term consistency determines the outcome, a device that fits into a daily routine at home is a practical advantage that matters.
Safe for Unsupervised Use
The lasers used in the osteoporosis trials are Class 3B or higher medical devices that can damage the eyes on direct exposure and require trained operators and protective eyewear. LED devices run at power levels that do not carry those risks. The Cura ProWave Deep Healing Pad is FDA Registered and ISO Certified, with 0 V/m EMF output, so it can be used safely at home without the supervision a clinical laser requires.
How the Cura ProWave Deep Healing Pad Delivers Light Therapy
Wavelengths
The Cura ProWave Deep Healing Pad is built around 120 medical-grade triple-chip LEDs: 240 light chips near-infrared at 850 nm and 120 light chips red at 660 nm. Both fall within the ranges documented in the osteoporosis research. The 660 nm red light sits in the band where light triggers the cellular energy response and where bone-specific effects have been measured: Tani et al. (2018) found 635 nm red light increased bone-formation markers in human osteoblasts, and Lim et al. (2014) showed 635 nm LED light inhibited bone-dissolving cell formation. The 850 nm near-infrared travels deeper toward bone tissue; it sits within the 810-940 nm range where Shokri et al. (2023) found all tested wavelengths improved bone density, and close to the 830 nm used in the Bossini (2012) and Mohammadzadeh (2024) studies that found improved bone repair and bone density gains in humans.
Power Density: Why It Matters
The Cura ProWave Deep Healing Pad delivers 200 mW/cm2, which is among the highest power density for a home-use LED device. Power density means how much light energy reaches each patch of skin. This matters for osteoporosis specifically because bone sits beneath skin, subcutaneous tissue, and muscle. Light loses intensity as it passes through each layer, so the energy reaching bone is always less than the energy at the surface. Higher surface power means more energy arrives at the target.
The dose-dependence pattern in bone research is clear. Huang et al. (2009) documented the biphasic dose response: underpowered treatments do not trigger the biological cascade, while overpowered treatments can reduce it. Bossini et al. (2012) found that both dosages they tested improved bone repair compared to controls, confirming that staying within the therapeutic window is what matters. At 200 mW/cm2 across a 20-minute session, the Cura ProWave Deep Healing Pad delivers more energy to the tissue than lower-powered devices can, which is what gives near-infrared its best chance of reaching bone tissue at depth.
Coverage Across Vulnerable Sites
The pad measures 18 x 8 inches, large enough to cover the hip, wrap along the lumbar spine, or cover the forearm, the sites most commonly affected by osteoporosis. Its flexible neoprene conforms to the body's contours so the LEDs stay in close contact with the skin across the treatment area. The strap system was designed to be easy to secure without help, which matters especially for older adults. Where a clinical laser probe treats one point at a time, the Cura ProWave Deep Healing Pad treats the full area at once.
Three Treatment Modes
The device runs in three modes: red only (660 nm), infrared only (850 nm), and combined. Red light stimulates bone-building cells and inhibits bone-dissolving cells at the surface level. Infrared reaches deeper, toward the bone tissue itself. Running each wavelength alone or together means treatment can be matched to the situation: combined mode for full-spectrum bone support addressing both cellular activity and deeper tissue, infrared mode when reaching bone at depth is the primary focus.
Pre-Set Modes and Guided Routine
The Cura ProWave Deep Healing Pad includes pre-set modes with parameters chosen to land within the effective range, removing the guesswork that undermines generic light-therapy devices. Light therapy follows a biphasic dose response where both too little and too much reduce the effect (Huang et al., 2009), so the pre-sets keep treatment in the therapeutic window. The device comes with a cellular restoration protocol and progress tools to help build a daily habit and track response over time, because consistency is the single biggest factor in bone outcomes. Bone renewal is slow, and the clinical trials tied their positive results to steady, repeated treatment courses. A device used only occasionally will not deliver what the research achieved.
CuraYou's Recommended Routine for Osteoporosis
Based on the research parameters and how light travels through tissue, CuraYou recommends daily 20-minute sessions in the combined red-and-infrared mode for osteoporosis. The combined mode delivers both surface-level wavelengths that affect bone cell activity and the deeper near-infrared wavelengths that reach bone tissue. For targeted treatment of a specific vulnerable site (hip, lumbar spine, or forearm), position the pad directly over that area and secure it with the strap. For people treating multiple sites, CuraYou's human support team can help design a rotation schedule.
Osteoporosis is a long-term condition, and bone density changes accumulate gradually. Early markers of bone-building activity can shift within weeks, but structural bone density changes measured on a DEXA scan typically require months of consistent use. The research supports staying consistent; the positive results in the clinical trials came from regular treatment courses, not occasional use.
Medical-Grade Quality and Real Support
The Cura ProWave Deep Healing Pad is FDA Registered and ISO Certified, with precise wavelengths within the documented therapeutic ranges. Its 0 V/m EMF rating means no electromagnetic field exposure during treatment, and the LEDs are rated for 50,000 hours, holding their output across years of daily use. It can be bought with an HSA or FSA card and is backed by up to a 3-year warranty. At CuraYou, real people are available to help tailor your routine and answer questions, and hundreds of verified customer reviews document the results people report.
Conclusion
The Cura ProWave Deep Healing Pad takes the research behind red and infrared light therapy for osteoporosis and builds it into a device made for daily home use. Its 660 nm red and 850 nm near-infrared LEDs sit within the wavelength range where Shokri et al. (2023) found all tested wavelengths improved bone density, and where three human studies have found significant bone density gains. Its 200 mW/cm2 power density is built to deliver the kind of dosing the research shows is needed to reach bone tissue at depth. Its 360-LED, 18 x 8 inch flexible pad treats the full area at once rather than one point at a time. The human trials show bone density markers responding within 8 weeks and structural density gains measurable at follow-up, with months of consistent use producing the clearest results. That timeline fits within CuraYou's 60-day risk-free return guarantee: enough time to establish a daily routine, observe early responses, and decide whether to continue, or a full refund if it is not for you.
